B12 vitamini sıçanlarda metotreksatın neden olduğu akciğer hasarını azaltır: Histopatolojik, immünohistokimyasal ve biyokimyasal bir çalışma

Amaç: Metotreksat (MTX) önemli bir kemoterapötik olup kanser hastalarında kullanılan önemli bir antikanserojen olmakla birlikte diğer dokularda yan etkilere yol açmaktadır. Bu yan etkiler arasında akciğer toksisitesi de yer almaktadır. B12 Vitamini güçlü bir antioksidandır ve reaktif oksijen türlerinin azalmasını sağlar. Bu çalışma, B12 vitamininin sıçan akciğerinde metotreksat kaynaklı hasara karşı koruma sağlayıp sağlayamayacağını belirlemek için tasarlanmıştır. Yöntem: Toplam 32 erkek Wistar albino sıçanı dört gruba ayrılmıştır: Kontrol grubuna (n=8) deney boyunca intraperitoneal (i.p.) salin uygulanmıştır. B12 vitamini (B12) grubuna (n=8) 3 μg/kg/i.p. 14 gün boyunca B12 vitamini verilmiştir. Metotreksat (MTX) grubuna 20 mg/ kg/i.p. tek doz (MTX) enjeksiyonu deneyin sekizinci gününde yapılmıştır. MTX+B12 grubuna deneyin sekizinci gününde MTX tek doz 20 mg/kg/ i.p. + 3 μg/kg/i.p. B12 vitamini günlük deney boyunca uygulandı. Elde edilen akciğer dokularına histopatolojik, immünohistokimyasal ve biyokimyasal yöntemler uygulanmıştır. Akciğer dokuları Masson’s Trikrom (MT) ile boyanmıştır. Ayrıca α-Sma, Laminin, PCNA ve TNF-α antikorları immünohistokimya ile boyandı. Akciğer doku homojenatlarında ise süperoksit dismutaz (SOD), katalaz (CAT) ve malondialdehit (MDA) seviyeleri değerlendirilmiştir. Bulgular: Metotreksat, MDA ve IL-6 seviyelerinde ve α-Sma, Laminin ve TNF-α ekspresyonunda ve akciğer dokusunda apoptotik hücre sayısında artışa neden olmuştur. Ayrıca MTX grubunda PCNA ekspresyonu ve SOD ve CAT seviyelerinde azalma görülmüştür. B12 vitamini, MDA ve IL-6 düzeylerindeki artışı ve α-Sma, Laminin ve TNF-α ekspresyonunu engellemiştir. B12 vitamininin antioksidan kapasiteyi artırdığı tespit edilmiştir. Sonuç: B12 vitamininin metotreksat kaynaklı akciğer toksisitesinde oksidatif stress, inflamasyon, fibrosis ve apoptosis gibi faktörler üzerinde etkili olduğu ve hasarı azalttığı görülmüştür. Bu çalışma, metotreksatın neden olduğu akciğer hasarı için B12 vitamini kullanımının faydalı olacağını göstermiştir. Kanser ilacı kullanımında yan etkileri azaltmada B12 vitamininin gözardı edilmemesi gerektiğini düşündürmektedir.

Vitamin B12 alleviates methotrexate-induced lung injury in rat: A histopathological, immunohistochemical and biochemical study

Objective: Methotrexate (MTX) is an important chemotherapeutic and an important anticarcinogen used in cancer patients, but it causes side effects in other tissues. Among these side effects is lung toxicity. Vitamin B12 is a powerful antioxidant and reduces reactive oxygen species. This study was designed to determine whether vitamin B12 could protect against methotrexate-induced damage in rat lungs. Methods: A total of 32 male Wistar albino rats were divided into four groups: The control group (n=8) received intraperitoneal (i.p.) saline throughout the experiment. Vitamin B12 group (B12) (n=8) 3 μg/ kg/i.p. Vitamin B12 was administered for 14 days. The methotrexate (MTX) group received a single dose MTX injection at 20 mg/kg/i.p. on the 8th day of the experiment. On the 8th day of the experiment, a single dose of MTX 20 mg/kg/i.p. was given to the MTX+B12 group. + 3 μg/kg/i.p. Vitamin B12 was administered daily throughout the experiment. Histopathological, immunohistochemical, and biochemical methods were applied to the obtained lung tissues. Lung tissues were stained with Masson’s Trichrome (MT). In addition, α-Sma, Laminin, PCNA, and TNF-α antibodies were stained by immunohistochemistry. Superoxide dismutase (SOD), catalase (CAT), and malondialdehyde (MDA) levels were evaluated in lung tissue homogenates. Results: MTX caused an increase in MDA and IL-6 levels and expression of α-Sma, Laminin, and TNF-α, and the number of apoptotic cells in lung tissue. It also caused a decrease in PCNA expression and SOD and CAT levels in the MTX group. Vitamin B12 inhibited the increase in MDA and IL-6 levels and the expression of α-Sma, Laminin, and TNF-α. Vitamin B12 was found to increase antioxidant capacity. Conclusion: Vitamin B12 has been shown to be effective on factors such as oxidative stress, inflammation, fibrosis, and apoptosis in MTX-induced lung toxicity and reduce damage. We observed that MTX stimulated lung injury decreased with vitamin B12 treatment It suggests that vitamin B12 should not be ignored in reducing side effects in cancer drug use.

___

  • 1. Ohbayashi M, Kubota S, Kawase A, Kohyama N, Kobayashi Y, Yamamoto T. Involvement of epithelial- mesenchymal transition in methotrexate-induced pulmonary fibrosis. J Toxicol Sci, 2014;39(2):319- 30.
  • 2. El-Sheikh AA, Morsy MA, Abdalla AM, Hamouda AH, Alhaider IA. Mechanisms of thymoquinone hepatorenal protection in methotrexate- induced toxicity in rats. Mediators Inflamm, 2015;2015:859383.
  • 3. Lee AM, Shandala T, Soo PP, Su YW, King TJ, Chen KM, et al. Effects of Resveratrol Supplementation on Methotrexate Chemotherapy-Induced Bone Loss. Nutrients, 2017;9(3).
  • 4. Akubovic BD, Donovan A, Webster PM, Shear NH. Methotrexate-induced pulmonary toxicity. Can Respir J, 2013;20(3):153-5.
  • 5. Salehi M, Miller R, Khaing M. Methotrexate-induced hypersensitivity pneumonitis appearing after 30 years of use: a case report. J Med Case Rep, 2017;11(1):174.
  • 6. Mohamed DI, Khairy E, Tawfek SS, Habib EK, Fetouh MA. Coenzyme Q10 attenuates lung and liver fibrosis via modulation of autophagy in methotrexate treated rat. Biomed Pharmacother.,2019;109:892-901.
  • 7. Ohbayashi M, Suzuki M, Yashiro Y, Fukuwaka S, Yasuda M, Kohyama N, et al. Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro. J Toxicol Sci, 2010;35(5):653-61.
  • 8. Ebrahimi R, Sepand MR. Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the IĸBα/NFĸB in rats. Daru, 2019;27(2):721-33.
  • 9. Shemesh A, Kundu K, Peleg R, Yossef R, Kaplanov I, Ghosh S, et al. NKp44-derived peptide binds proliferating cell nuclear antigen and mediates tumor cell death. Front Immunol, 2018;9:1114.
  • 10. Moghadam AR, Tutunchi S, Namvaran-Abbas-Abad A, Yazdi M, Bonyadi F, Mohajeri D, et al. Pre- administration of turmeric prevents methotrexate- induced liver toxicity and oxidative stress. BMC Complement Altern Med, 2015;15:246.
  • 11. Selimoglu Sen H, Sen V, Bozkurt M, Turkcu G, Guzel A, Sezgi C, et al. Carvacrol and pomegranate extract in treating methotrexate-induced lung oxidative injury in rats. Med Sci Monit, 2014;20:1983-90.
  • 12. Stojiljkovic N, Ilic S, Jakovljevic V, Stojanovic N, Stojnev S, Kocic H, et al. The encapsulation of lycopene in nanoliposomes enhancesits protective potential in methotrexate-induced kidney injury model. Oxid Med Cell Longev, 2018;2018:2627917.
  • 13. Mahmoud AM, Hussein OE, Hozayen WG, Abd El- Twab SM. Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARγ and Nrf2: protective effect of 18β-glycyrrhetinic acid. Chem Biol Interact, 2017;270:59-72.
  • 14. Chu H, Jiang S, Liu Q, Ma Y, Zhu X, Liang M, et al. Sirtuin1 protects against systemic sclerosis-related pulmonary fibrosis by decreasing proinflammatory and profibrotic processes. Am J Respir Cell Mol Biol, 2018;58(1):28-39.
  • 15. Kim YJ, Song M, Ryu JC. Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology, 2009;256(3):183-90.
  • 16. Sun P, Li L, Zhao C, Pan M, Qian Z, Su X. Deficiency of alpha7 nicotinic acetylcholine receptor attenuates bleomycin-induced lung fibrosis in mice. Mol Med, 2017;23:34-9.
  • 17. Lee CM, Cho SJ, Cho WK, Park JW, Lee JH, Choi AM, et al. Laminin alpha1 is a genetic modifier of TGF- beta1-stimulated pulmonary fibrosis. JCI Insight, 2018;3(18).
  • 18. Su Y, Gu H, Weng D, Zhou Y, Li Q, Zhang F, et al. Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease. Medicine (Baltimore), 2017;96(18):e6617.
  • 19. Zaki SM, Hussein GHA, Khalil HMA, Abd Algaleel WA. Febuxostat ameliorates methotrexate-induced lung damage. Folia morphologica, 2020.
  • 20. Kalemci S, Akpinar O, Dere Y, Sarihan A, Zeybek A, Tanriverdi O. Efficacy of clarithromycin as a protective agent in the methotrexate- induced pulmonary fibrosis model. Kardiochir Torakochirurgia Pol, 2018;15(4):209-12.
  • 21. Miyazono Y, Gao F, Horie T. Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats. Scandinavian journal of gastroenterology, 2004;39(11):1119-27.
  • 22. Mahalle N, Bhide V, Greibe E, Heegaard CW, Nexo E, Fedosov SN, et al. Comparative Bioavailability of Synthetic B12 and Dietary Vitamin B12 Present in Cow and Buffalo Milk: A Prospective Study in Lactovegetarian Indians. Nutrients, 2019;11(2).
  • 23. Banerjee R. B12 trafficking in mammals: A for coenzyme escort service. ACS chemical biology, 2006;1(3):149-59.
  • 24. Li F, Bahnson EM, Wilder J, Siletzky R, Hagaman J, Nickekeit V, et al. Oral high dose vitamin B12 decreases renal superoxide and post-ischemia/ reperfusion injury in mice. Redox Biol, 2020;32:101504.
  • 25. Samblas M, Martinez JA, Milagro F. Folic Acid Improves the Inflammatory Response in LPS- Activated THP-1 Macrophages. Mediators Inflamm, 2018;2018:1312626.
  • 26. Moreira ES, Brasch NE, Yun J. Vitamin B12 protects against superoxide-induced cell injury in human aortic endothelial cells. Free Radic Biol Med, 2011;51(4):876-83.
  • 27. van de Lagemaat EE, de Groot L. Vitamin B(12) in Relation to Oxidative Stress: A Systematic Review. 2019;11(2).
  • 28. Karabulut D, Ulusoy HB, Kaymak E, Sonmez MF. Therapeutic effects of pentoxifylline on diabetic heart tissue via NOS. Anatol J Cardiol, 2016;16(5):310-5.
  • 29. Sonmez MF, Ozdemir S, Guzel M, Kaymak E. The ameliorative effects of vinpocetine on apoptosis and HSP-70 expression in testicular torsion in rats. Biotechnic & histochemistry : official publication of the Biological Stain Commission, 2017;92(2):92-9.
  • 30. Tang KT, Chen YH, Lin CH, Chen DY. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C. Sci Rep, 2016;6:33104.
  • 31. Cooper I, Last D, Guez D, Sharabi S, Elhaik Goldman S, Lubitz I, et al. Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors. J Cereb Blood Flow Metab, 2015;35(6):967-76.
  • 32. Wen J, Maxwell RR, Wolf AJ, Spira M, Gulinello ME, Cole PD. Methotrexate causes persistent deficits in memory and executive function in a juvenile animal model. Neuropharmacology, 2018;139:76-84.
  • 33. Akbulut S, Elbe H, Eris C, Dogan Z, Toprak G, Otan E, et al. Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats. World J Gastroenterol, 2014;20(29):10158-65.
  • 34. Devrim E, Cetin R, Kilicoglu B, Erguder BI, Avci A, Durak I. Methotrexate causes oxidative stress in rat kidney tissues. Ren Fail, 2005;27(6):771-3.
  • 35. Kahraman H, Kurutas E, Tokur M, Bozkurt S, Ciralik H, Kabakci B, et al. Protective effects of erythropoietin and N-acetylcysteine on methotrexate-induced lung injury in rats. Balkan Med J, 2013;30(1):99-104.
  • 36. Tag HM. Hepatoprotective effect of mulberry (Morus nigra) leaves extract against methotrexate induced hepatotoxicity in male albino rat. BMC Complement Altern Med, 2015;15:252.
  • 37. Oliveira FMS, da Paixao Matias PH, Kraemer L, Gazzinelli-Guimaraes AC, Santos FV, Amorim CCO, et al. Comorbidity associated to Ascaris suum infection during pulmonary fibrosis exacerbates chronic lung and liver inflammation and dysfunction but not affect the parasite cycle in mice. PLoS Negl Trop Dis, 2019;13(11):e0007896.
  • 38. Goodwin J, Choi H, Hsieh MH, Neugent ML, Ahn JM, Hayenga HN, et al. Targeting Hypoxia-Inducible Factor-1alpha/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin- induced Pulmonary Fibrosis. Am J Respir Cell Mol Biol, 2018;58(2):216-31.
  • 39. Horie M, Saito A, Mikami Y, Ohshima M, Morishita Y, Nakajima J, et al. Characterization of human lung cancer-associated fibroblasts in three-dimensional in vitro co-culture model. Biochem Biophys Res Commun, 2012;423(1):158-63.
  • 40. Tsoyi K, Chu SG, Patino-Jaramillo NG, Wilder J, Villalba J, Doyle-Eisele M, et al. Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148. Am J Respir Cell Mol Biol, 2018;58(2):208-15.
  • 41. Singer II, Kawka DW, Mcnally SM, Eiermann GJ, Metzger JM, Peterson LB. Extensive Laminin and Basement-Membrane Accumulation Occurs at the Onset of Bleomycin-Induced Rodent Pulmonary Fibrosis. Am J Pathol, 1986;125(2):258-68.
  • 42. Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R. Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment. Front Med (Lausanne), 2019;6:238.
  • 43. Herfarth HH, Kappelman MD, Long MD, Isaacs KL. Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases. Inflamm Bowel Dis, 2016;22(1):224-33.
  • 44. Ahmad A, Afroz N, Gupta UD, Ahmad R. Vitamin B12 supplement alleviates N’-nitrosodimethylamine- induced hepatic fibrosis in rats. Pharm Biol, 2014.
  • 45. Isoda K, Kagaya N, Akamatsu S, Hayashi S, Tamesada M, Watanabe A, et al. Hepatoprotective effect of vitamin B12 on dimethylnitrosamine-induced liver injury. Biol Pharm Bull, 2008;31(2):309-11.
  • 46. Mammadov R, Suleyman B, Akturan S, Cimen FK, Kurt N, Suleyman Z, et al. Effect of lutein on methotrexate-induced oxidative lung damage in rats: a biochemical and histopathological assessment. Korean J Intern Med, 2019;34(6):1279- 86.
  • 47. Abdel-Daim MM, Khalifa HA, Abushouk AI, Dkhil MA, Al-Quraishy SA. Diosmin Attenuates Methotrexate- Induced Hepatic, Renal, and Cardiac Injury: A Biochemical and Histopathological Study in Mice. Oxid Med Cell Longev, 2017;2017:3281670.
  • 48. Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol, 2009;2(2):103-21.
  • 49. Kemse NG, Kale AA, Joshi SR. A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension. PLoS One, 2014;9(11):e111902.
  • 50. Sampaio AL, Dalli J, Brancaleone V, D’Acquisto F, Perretti M, Wheatley C. Biphasic modulation of NOS expression, protein and nitrite products by hydroxocobalamin underlies its protective effect in endotoxemic shock: downstream regulation of COX-2, IL-1beta, TNF-alpha, IL-6, and HMGB1 expression. Mediators Inflamm, 2013;2013:741804.
  • 51. Koppelmann T, Pollak Y, Mogilner J, Bejar J, Coran AG, Sukhotnik I. Dietary L-arginine supplementation reduces Methotrexate-induced intestinal mucosal injury in rat. BMC Gastroenterol, 2012;12:41.
  • 52. Vasiliausha SR, Beltrame FL, de Santi F, Cerri PS, Caneguim BH, Sasso-Cerri E. Seminiferous epithelium damage after short period of busulphan treatment in adult rats and vitamin B12 efficacy in the recovery of spermatogonial germ cells. Int J Exp Pathol, 2016;97(4):317-28.
  • 53. Bhattacharjee A, Prasad SK, Pal S, Maji B, Syamal AK, Banerjee A, et al. Protective efficacy of folic acid and vitamin B12 against nicotine-induced toxicity in pancreatic islets of the rat. Interdiscip Toxicol, 2015;8(2):103-11.
  • 54. Eki Nci-Akdemi RF, Yildirim S, Kandemi RF, Gulci NI, Kucukler S, Saglam YS, et al. The effects of casticin and myricetin on liver damage induced by methotrexate in rats. Iran J Basic Med Sci, 2018;21(12):1281-8.
  • 55. Abdulkhaleq FM, Alhussainy TM, Badr MM, Khalil AAA, Gammoh O, Ghanim BY, et al. Antioxidative stress effects of vitamins C, E, and B12, and their combination can protect the liver against acetaminophen-induced hepatotoxicity in rats. Drug Des Devel Ther, 2018;12:3525-33.
Türk Hijyen ve Deneysel Biyoloji Dergisi-Cover
  • ISSN: 0377-9777
  • Başlangıç: 1938
  • Yayıncı: Türkiye Halk Sağlığı Kurumu
Sayıdaki Diğer Makaleler

Periferik arter hastalarinda yükselmiş serum homositrulin düzeyleri

Duygu ERYAVUZ ONMAZ, Canan AYDOĞAN, Nazif AYGÜL, Abdullah SİVRİKAYA, Sedat ABUŞOĞLU, Ali ÜNLÜ

Inula viscosa metanol ve hekzan ekstraktlarının antibakteriyel ve antikanserojenik etkilerinin incelenmesi

Berna ERDAL, Bahar YILMAZ, Bensu BAYLAN

Borik asitin dezenfektan etkinliğinin araştırılması

Yasemin ZER, Fatma Nur KARABACAK, Ayşe BÜYÜKTAŞ MANAY

Hipoksiye bağlı bağırsak hasarına karşı klorokin tedavisinin hafifletici etkileri: histolojik ve immünohistokimyasal bir çalışma

Ali Tuğrul AKIN, Emin KAYMAK, Emel ÖZTÜRK, Tayfun CEYLAN, Betül YALÇIN, Kemal Erdem BAŞARAN, Derya KARABULUT, Züleyha DOĞANYİĞİT, Saim ÖZDAMAR, Birkan YAKAN

SARS-CoV-2 pozitif sağlık çalışanlarının gerçek zamanlı PCR döngü eşik değeri, klinik ve epidemiyolojik özelliklerinin değerlendirilmesi

Gül BAYRAM, Harun GÜLBUDAK, Aslıhan BEKCİ, Seda TEZCAN ÜLGER, Gülçin YAPICI, Gönül ASLAN

Klinik vakalardan izole edilen metisilin dirençli Staphylococcus aureus (MRSA) suşlarına siprofloksasin ve yeşil çay ekstraktının sinerjik antibakteriyel etkisinin araştırılması

Yalçın DİCLE, Halil YAZGI, Mehmet Veysel COŞKUN, Zeynal TOPALCENGİZ

Araştırma hastanesinde yoğun bakım ünitelerindeki hastalardan izole edilen Candida türlerinin epidemiyolojisi ve antifungal duyarlılığı

Esma EREN, Hafize SAV, Zehra BEŞTEPE DURSUN

Kronik hastalığı olan erişkinlerin 2015-2017 yılları arasında influenzaya karşı aşılanma durumları

Halil EKİNCİ, Turan BUZGAN, Banu EKİNCİ, Fatih KARA, Bekir KESKİNKILIÇ, Hasan IRMAK

B12 vitamini sıçanlarda metotreksatın neden olduğu akciğer hasarını azaltır: Histopatolojik, immünohistokimyasal ve biyokimyasal bir çalışma

Emin KAYMAK, Derya KARABULUT, Emel ÖZTÜRK, Ali Tuğrul AKIN, Nurhan KULOĞLU, Birkan YAKAN

Sağlık alanındaki biyoteknolojik ürünlerin üretimi için mantarların kullanımı

Şule Aybüke YAVUZ, Ülküye Dudu GÜL